FDA Approvals - OrthoLogic Announces Year End 2006 Financial Results (PrimeNewswire via Yahoo!
OrthoLogic Announces Year End 2006 Financial Results (PrimeNewswire via Yahoo! Finance)
TEMPE, Ariz., March 14, 2007 -- OrthoLogic Corp. today announced financial results for the year ending December 31, 2006. Net loss was $31.9 million, or $0.78 per share versus a net loss of $27.2 million or $0.72 per share for the year ended December 31, 2005.
Mylan Gets Tentative FDA Depakote OK (AP via Yahoo! Finance)
Drug maker Mylan Laboratories Inc. said Wednesday that its Mylan Pharmaceuticals unit received tentative approval from the Food and Drug Administration to sell a generic version of Abbott Laboratories' Depakote tablets.
Critical Therapeutics and DEY, L.P. Enter into Co-Promotion Agreement for Respiratory Care Products (Business Wire via Yahoo! Finance)
LEXINGTON, Mass. & NAPA, Calif.----Critical Therapeutics, Inc. and DEY, L.P., an affiliate of Merck KGaA of Darmstadt, Germany, today announced the signing of a definitive co-promotion agreement that leverages the expertise of both companies in the U.S. respiratory care market.